Substituted imidazo [4,5-B]Pyridyl-1H-lndole-2-Carboxamide compound

PK141424AUndetermined Publication Date: 2012-07-04SANOFI AVENTIS SA

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
SANOFI AVENTIS SA
Publication Date
2012-07-04
Patent Text Reader

Abstract

The invention relates to a compound of general formula (I) in which X1, X2, X3 and X4 represent, independently of each other, a nitrogen atom or a group C-R1; W represents an oxygen or sulfur atom; n is equal to 0, 1, 2 or 3; Y represents an optionally substituted aryl or heteroaryl; A represents the group of formula: Z1, Z2, Z3 and Z4 represent, independently of each other, a nitrogen atom or a group C-R2, Ra and Rb together form, with the carbon atoms that bear them, either a partially unsaturated cycloalkyl, or an aryl; or a heterocycle, or a heteroaryl, which is 5- to 7- membered, comprising from 1 to 3 heteroatoms chosen from 0, S and N; this cycloalkyl, this aryl, this heterocycle or this heteroaryl possibly being substituted with one or more substituents R3; preparation process and a pharmaceutical composition comprising thereof.
Need to check novelty before this filing date? Find Prior Art